Insider trade

Trisalus Life Sciences (TLSI): Director bought ~$125K

William Valle, Director at Trisalus Life Sciences, bought ~$125K of Trisalus Life Sciences shares.

~$125K
Approx. value · 30K sh @ $4.10
30K
Holds after · shares reported
Traded
Feb 23, 2026
Filed
Feb 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
  2. Feb 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 3, 2026, Dr. Arjun “JJ” Desai informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of the Board, effective immediately.”
  3. Feb 19, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  4. Feb 23, 2026 · this disclosureInsider · 10 days before resultsDirector purchased ~$125K of TLSI shares in the open market

What came next

  1. Feb 23, 2026Insider · 4 peopleInsiders: 5 purchases (~$1.7M)
  2. Mar 5, 2026Company filing · Form 8-K · ResultsReported its results
  3. Mar 11, 2026Insider · 5 peopleInsiders: 5 sales (~$38K)
  4. Mar 12, 2026Insider · 4 peopleInsiders: 4 sales (~$26K)
  5. Mar 16, 2026Insider · 4 peopleInsiders: 4 sales (~$8K)
  6. Mar 17, 2026InsiderCEO sold ~$61K of TLSI shares in the open market
  7. Apr 1, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 1, 2026, TriSalus Life Sciences, Inc. (the “Company”) entered into an offer letter with Dr. Richard Marshall for the position of Chief Medical Officer.”
  8. Apr 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.”
  9. May 12, 2026Company filing · Form 8-K · ResultsReported its results
  10. May 15, 2026Insider · 6 peopleInsiders: 6 purchases (~$1.8M), 1 sale (~$1K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Trisalus Life Sciences

For Trisalus Life Sciences, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TLSI page.

How this filing works

Explore the data

Common questions

Which Trisalus Life Sciences (TLSI) insider traded, and how much?

William Valle, Director at Trisalus Life Sciences, bought ~$125K of Trisalus Life Sciences shares. 30K shares at $4.10, open market.

When did it happen, and when was it made public?

Traded: Feb 23, 2026. Filed: Feb 23, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Trisalus Life Sciences recently?

For Trisalus Life Sciences, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the TLSI page.

Does this mean TLSI stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Trisalus Life Sciences

Everything OQRO holds on this company is on its TLSI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data